To highlight the diagnosis, implications, and potential treatment options of Lysosomal Acid Lipase Deficiency (LAL-D) in a patient presenting with hepatosteatosis.
Key Findings:
LAL-D is a rare autosomal-recessive lysosomal storage disease with significant clinical implications.
Complete lack of LAL activity leads to Wolman disease, which is fatal in infancy, while minimal residual activity leads to cholesterol ester storage disease (CESD), which can progress to severe liver disease.
Characteristic liver steatosis appears orange due to predominant cholesterol deposition, differing from typical fatty liver presentations.
Interpretation:
LAL-D can lead to severe liver disease and complications if not diagnosed early. Awareness of this condition is essential for timely intervention and treatment options, including enzyme replacement therapy.
Limitations:
The case study is based on a single patient, limiting generalizability.
Long-term outcomes and management strategies for LAL-D are not discussed, which may affect understanding of the disease.
Conclusion:
Timely diagnosis of LAL-D is critical, as enzyme replacement therapy is available and can be life-saving.
